Measurement of activated clotting time and whole blood heparin concentration during cardiopulmonary bypass

被引：0
|
作者：
Takashi Watanabe
Kazuaki Shirota
机构：
[1] Nagoya University School of Medicine,Department of Thoracic Surgery
来源：
The Japanese Journal of Thoracic and Cardiovascular Surgery | 1998年 / 46卷 / 6期
关键词：
Heparin; Cardiopulmonary Bypass; Activate Clotting Time; Heparin Dose; Heparin Concentration;
D O I：
10.1007/BF03250593
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：530 / 530
相关论文
共 50 条
  • [31] Activated clotting time systems vary in precision and bias and are not interchangeable when following heparin management protocols during cardiopulmonary bypass
    Welsby I.J.
    McDonnell E.
    El-Moalem H.
    Stafford-Smith M.
    Toffaletti J.G.
    Journal of Clinical Monitoring and Computing, 2002, 17 (05) : 287 - 292
  • [32] EFFECT OF APROTININ ON ACTIVATED CLOTTING TIME, WHOLE-BLOOD AND PLASMA HEPARIN MEASUREMENTS
    DESPOTIS, GJ
    JOIST, JH
    JOINERMAIER, D
    ALSOUFIEV, AL
    TRIANTAFILLOU, AN
    GOODNOUGH, LT
    SANTORO, SA
    LAPPAS, DG
    ANNALS OF THORACIC SURGERY, 1995, 59 (01): : 106 - 111
  • [33] HEPARIN CONCENTRATIONS CORRELATED TO THE ACTIVATED WHOLE-BLOOD CLOTTING TIME (ACT) DURING EXTRACORPOREAL-CIRCULATION
    STENBJERG, S
    BERG, E
    ALBRECHTSEN, OK
    THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 236 - 236
  • [34] ACTIVATED COAGULATION TIME METHOD FOR CONTROL OF HEPARIN IS RELIABLE DURING CARDIOPULMONARY BYPASS
    COHEN, JA
    ANESTHESIOLOGY, 1984, 60 (02) : 121 - 124
  • [35] A comparative analysis of four activated clotting time measurement devices in cardiac surgery with cardiopulmonary bypass
    Li, Han
    Serrick, Cyril
    Rao, Vivek
    Yip, Paul M.
    PERFUSION-UK, 2021, 36 (06): : 610 - 619
  • [36] Investigation of activated blood substances in the measuring of whole blood clotting time during hemodialysis
    不详
    BLOOD PURIFICATION, 2005, 23 (05) : 409 - 409
  • [37] Heparin concentration versus activated clotting time for cardiac surgery
    Lupei, Monica I.
    Cooper, Emily H.
    Kaizer, Alexander M.
    Konia, Mojca R.
    ANESTHESIA AND ANALGESIA, 2020, 130 : 138 - 138
  • [38] Aprotinin prolongs activated and nonactivated whole blood clotting time and potentiates the effect of heparin in vitro
    Despotis, GJ
    Filos, KS
    Levine, V
    Alsoufiev, A
    Spitznagel, E
    ANESTHESIA AND ANALGESIA, 1996, 82 (06): : 1126 - 1131
  • [39] Extrinsic pathway-associated activated clotting time for anticoagulation monitoring during cardiopulmonary bypass
    Gu, YJ
    Huyzen, RJ
    vanOeveren, W
    ANESTHESIA AND ANALGESIA, 1996, 83 (02): : 433 - 433
  • [40] ADEQUATE ANTICOAGULATION DURING CARDIOPULMONARY BYPASS DETERMINED BY ACTIVATED CLOTTING TIME AND APPEARANCE OF FIBRIN MONOMER
    YOUNG, JA
    KISKER, CT
    DOTY, DB
    ANNALS OF THORACIC SURGERY, 1978, 26 (03): : 231 - 240
12345